Resonant Capital Advisors, LLC Johnson & Johnson Transaction History

Resonant Capital Advisors, LLC

$1.35 Billion
Q4 2024

A detailed history of Resonant Capital Advisors, LLC transactions in Johnson & Johnson stock. As of the latest transaction made, Resonant Capital Advisors, LLC holds 26,287 shares of JNJ stock, worth $4.4 Million. This represents 0.28% of its overall portfolio holdings.

Number of Shares

26,287

Previous 25,931 1.37%

Holding current value

$4.4 Million

Previous $4.2 Million 9.54%

% of portfolio

0.28%

Previous 0.31%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Jan 24, 2025	BUY	$143.34 - $165.86 $51,029 - $59,046	356 Added 1.37%	26,287 $3.8 Million
Q3 2024 Oct 18, 2024	BUY	$145.48 - $167.38 $105,909 - $121,852	728 Added 2.89%	25,931 $4.2 Million
Q2 2024 Aug 01, 2024	SELL	$144.38 - $157.78 $160,983 - $175,924	-1,115 Reduced 4.24%	25,203 $3.68 Million
Q1 2024 May 01, 2024	BUY	$155.22 - $162.74 $204,735 - $214,654	1,319 Added 5.28%	26,318 $4.16 Million
Q4 2023 Jan 31, 2024	SELL	$145.6 - $158.88 $260,478 - $284,236	-1,789 Reduced 6.68%	24,999 $3.92 Million
Q3 2023 Oct 31, 2023	BUY	$155.75 - $174.48 $325,517 - $364,663	2,090 Added 8.46%	26,788 $4.17 Million
Q2 2023 Jul 25, 2023	BUY	$154.35 - $166.11 $329,382 - $354,478	2,134 Added 9.46%	24,698 $4.09 Million
Q1 2023 Apr 21, 2023	SELL	$151.05 - $180.26 $272,645 - $325,369	-1,805 Reduced 7.41%	22,564 $3.5 Million
Q4 2022 Jan 23, 2023	BUY	$160.2 - $179.79 $187,594 - $210,534	1,171 Added 5.05%	24,369 $0
Q3 2022 Oct 20, 2022	BUY	$161.33 - $179.52 $85,827 - $95,504	532 Added 2.35%	23,198 $3.79 Million
Q2 2022 Jul 12, 2022	BUY	$168.19 - $186.01 $29,769 - $32,923	177 Added 0.79%	22,666 $4.02 Million
Q1 2022 Apr 19, 2022	BUY	$158.14 - $179.59 $251,442 - $285,548	1,590 Added 7.61%	22,489 $4.01 Million
Q4 2021 Jan 26, 2022	BUY	$155.93 - $173.01 $506,928 - $562,455	3,251 Added 18.42%	20,899 $3.58 Million
Q3 2021 Oct 18, 2021	BUY	$161.5 - $179.47 $311,856 - $346,556	1,931 Added 12.29%	17,648 $2.85 Million
Q2 2021 Jul 16, 2021	BUY	$159.48 - $171.07 $54,063 - $57,992	339 Added 2.2%	15,717 $2.59 Million
Q1 2021 Apr 28, 2021	BUY	$153.07 - $170.48 $190,112 - $211,736	1,242 Added 8.79%	15,378 $2.53 Million
Q4 2020 Jan 15, 2021	BUY	$137.11 - $157.38 $85,830 - $98,519	626 Added 4.63%	14,136 $2.23 Million
Q3 2020 Nov 03, 2020	SELL	$140.38 - $153.83 $63,030 - $69,069	-449 Reduced 3.22%	13,510 $2.01 Million
Q2 2020 Aug 05, 2020	SELL	$128.81 - $155.51 $542,290 - $654,697	-4,210 Reduced 23.17%	13,959 $1.96 Million
Q1 2020 May 14, 2020	BUY	$111.14 - $153.99 $113,807 - $157,685	1,024 Added 5.97%	18,169 $2.38 Million
Q4 2019 Feb 18, 2020	BUY	$127.5 - $146.44 $2.19 Million - $2.51 Million	17,145 New	17,145 $2.5 Million

Others Institutions Holding JNJ

# of Institutions

4,525

Shares Held

1.73B

Call Options Held

16.8M

Put Options Held

13.9M

View Full List

About JOHNSON & JOHNSON

Ticker JNJ
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,614,479,872
Market Cap $437B
Description
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...

More about JNJ

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Resonant Capital Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Resonant Capital Advisors, LLC with notifications on news.

Account

Resonant Capital Advisors, LLC Johnson & Johnson Transaction History